VIVS — VivoSim Labs, Inc. · P/E 0.7, rev $131.0K

VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.

Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.

Use this VIVS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VIVS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VIVS SEC filings page. Lician reads the product cache first so this HTML stays unique to VivoSim Labs, Inc. even when a live quote feed is slow.